A curve ball from the FDA for Repros Therapeutics Inc. played foul with the company's shares as investors learned that U.S. regulators have switched the firm's pre-new drug application meeting from a type B to a less-routine type C session in the first half of next month. Read More
Amgen Inc. is throwing a wrench in the gears advancing Sanofi SA's and Regeneron Pharmaceuticals Inc.'s high cholesterol drug alirocumab, seeking an injunction to block the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor's manufacture and sale over alleged infringement on patents protecting Amgen's own anti-PCSK9 therapy, evolocumab, now under regulatory review. Read More
HONG KONG - A multidisciplinary research team from the Singapore-Massachusetts Institute of Technology (MIT) Alliance in Research and Technology (SMART) has identified a unique set of biophysical markers that are predictive for multipotent mesenchymal stromal cells in bone marrow, which should make it easier to develop stem cell-based therapies. Read More
NEW DELHI – The Indian drug pricing regulator is caught in a bitter wrangle between the pharmaceutical industry and public health organizations over recent and contradictory government orders that first called for a cap on drug prices and then U-turned. Read More
BOGOTA, Colombia – Cuban and Chinese authorities are working together to boost the island´s biotech production through a series of bilateral cooperation agreements that have been in place since 2001. Read More
Tetraphase Pharmaceuticals Inc., of Watertown, Mass., said it priced a public offering of 3.95 million shares at $19 per share for gross proceeds of about $75 million. Read More
Noven Pharmaceuticals Inc., of Miami, said it filed a lawsuit in the U.S. District Court of New Jersey against units of Actavis plc, of Dublin, including Actavis Laboratories FL Inc., Actavis Pharma Inc. and Actavis Inc. alleging infringement of certain Noven patents. Read More
Globeimmune Inc., of Louisville, Colo., reported data from 11 chordoma patients in its phase I trial of GI-6301 at the Connective Tissue Oncology Society meeting in Berlin, showing the Tarmogen candidate, a yeast-brachyury vaccine, was generally well tolerated, immunogenic and showed evidence of clinical activity in both advanced epithelial cancers and chordomas. Read More
Roche AG, of Basel, Switzerland, and DKSH Business Unit Healthcare, an Asia-focused market expansion services provider, inked a deal for DKSH to continue providing services for Roche's full pharma product portfolio in Cambodia, Hong Kong, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam. Read More
Glasoxmithkline plc, of London, said data published in Respiratory Medicine showed positive results from a third lung function study comparing the efficacy and safety of Anoro Ellipta (umeclidinium /vilanterol), the combination long-acting muscarinic antagonist (LAMA)/long-acting beta2-adrenergic agonist, with the LAMA tiotropium, administered in the Handihaler inhaler, in patients with chronic obstructive pulmonary disease. Read More
Researchers from the Israeli Weizman Institute have shown that the metabolic effects of jet lag are due in part to the disruption of circadian rhythms of the microbiome. Shift workers as well as frequent travelers across time zones are prone to metabolic problems. Read More
